Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer

Cancer Letters

Volumn 242, Issue 1, 2006, Pages 20-27

  Wang, Jun ^a   Wu, Kaichun ^a   Bai, Feihu ^a   Zhai, Huihong ^a   Xie, Huahong ^a   Du, Yulei ^a   Liang, Jie ^a   Han, Shuang ^a   Chen, Yu ^a   Lin, Tao ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Angiopoietin; Cyclooxygenase; Gastric cancer; Hypoxia

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ANGIOPOIETIN 2; CELECOXIB; COBALT CHLORIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; GENISTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STOMACH CANCER; UPREGULATION;

ANGIOPOIETIN-2; ANGIOPOIETINS; ANOXIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PYRAZOLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SULFONAMIDES; UP-REGULATION;

EID: 33749250714     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.10.030     Document Type: Article

References (38)

1. Hopfl G., Ogunshola O., and Gassmann M. HIFs and tumors-causes and consequences. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R608-R623
2. Wang G.L., Jiang B.H., Rue E.A., and Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix- loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92 (1995) 5510-5514
3. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
4. Ikeda E., Achen M.G., Breier G., and Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cell. J. Biol. Chem. 270 (1995) 19761-19766
5. Guo P., Imanishi Y., Cackowski F.C., Jarzynka M.J., Tao H.Q., Nishikawa R., et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 {gamma} 2 correlates with the invasiveness of human glioma. Am. J. Pathol. 166 (2005) 877-890
6. Etoh T., Inoue H., Tanaka S., Barnard G.F., Kitano S., and Mori M. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res. 61 (2001) 2145-2153
7. Oh H., Takagi H., Suzuma K., Otani A., Matsumura M., and Honda Y. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274 (1999) 15732-15739
8. Mandriota S.J., and Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83 (1998) 852-859
9. Kelly B.D., Hackett S.F., Hirota K., Oshima Y., Cai Z., Berg-Dixon S., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93 (2003) 1074-1081
10. Nilsson I., Shibuya M., and Wennstrom S. Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp. Cell Res. 299 (2004) 476-485
11. Yuan H.T., Yang S.P., and Woolf A.S. Hypoxia upregulates angiopoietin-2, a tie-2 ligand in mouse mesangial cells. Kidney Int. 58 (2000) 1912-1919
12. Pichiule P., Chavez J.C., and LaManna J.C. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J. Biol. Chem. 279 (2004) 12171-12180
13. Liu C., Shi Y., Han Z., Pan Y., Liu N., Han S., et al. Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO. Biochem. Biophys. Res. Commun. 312 (2003) 780-786
14. Wong M.P., Chan S.Y., Fu K.H., Leung S.Y., Cheung N., Yuen S.T., and Chung L.P. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer 29 (2000) 11-22
15. Park J.H., Kim T.Y., Jong H.S., Kim T.Y., Chun Y.S., Park J.W., et al. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin. Cancer Res. 9 (2003) 433-440
16. Liu C., Shi Y., Du Y., Ning X., Liu N., Huang D., et al. Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Exp. Cell Res. (2005) (Epub ahead of print)
17. Eibl G., Bruemmer D., Okada Y., Duffy J.P., Law R.E., Reber H.A., and Hines O.J. PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 306 (2003) 887-897
18. Wang G.L., Jiang B.H., and Semenza G.L. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216 (1995) 669-675
19. Buchler P., Reber H.A., Buchler M.W., Friess H., Lavey R.S., and Hines O.J. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer 100 (2004) 201-210
20. Liu X.H., Kirschenbaum A., Yao S., Stearns M.E., Holland J.F., Claffey K., and Levine A.C. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastas. 17 (1999) 687-694
21. Torimura T., Ueno T., Kin M., Harada R., Taniguchi E., Nakamura T., et al. Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. J. Hepatol. 40 (2004) 799-807
22. Sugimachi K., Tanaka S., Taguchi K., Aishima S., Shimada M., and Tsuneyoshi M. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J. Clin. Pathol. 56 (2003) 854-860
23. Maxwell P.H., and Ratcliffe P.J. Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 13 (2002) 29-37
24. Yeo E.J., Chun Y.S., Cho Y.S., Kim J., Lee J.C., Kim M.S., and Park J.W. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl Cancer Inst. 95 (2003) 516-525
25. Schmedtje Jr. J.F., Ji Y.S., Liu W.L., DuBois R.N., and Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272 (1997) 601-608
26. Xu Q., Ji Y.S., and Schmedtje Jr. J.F. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure. J. Biol. Chem. 275 (2000) 24583-24839
27. Yan S.F., Lu J., Zou Y.S., Soh-Won J., Cohen D.M., Buttrick P.M., et al. Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274 (1999) 15030-15040
28. Bonazzi A., Mastyugin V., Mieyal P.A., Dunn M.W., and Laniado-Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem. 275 (2000) 2837-2844
29. Sales K.J., Katz A.A., Howard B., Soeters R.P., Millar R.P., and Jabbour H.N. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res. 62 (2002) 424-432
30. Lukiw W.J., Ottlecz A., Lambrou G., Grueninger M., Finley J., Thompson H.W., and Bazan N.G. Coordinate activation of HIF-1 and NF-kB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4163-4170
31. Mandriota S.J., Pyke C., Di S.C., Quinodoz P., Pittet B., and Pepper M.S. Hypoxia-inducible angiopoietin-2 expression is mimicked by iodonium compounds and occurs in the rat brain and skin in response to systemic hypoxia and tissue ischemia. Am. J. Pathol. 156 (2000) 2077-2089
32. Liu X.H., Kirschenbaum A., Lu M., Yao S., Dosoretz A., Holland J.F., and Levine A.C. Prostaglandin E2 induces hypoxia-inducible factor-1a stabilization and nuclear localization in a human prostate cancer cell line. J. Biol. Chem. 277 (2002) 50081-50086
33. Fukuda R., Kelly B., and Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63 (2003) 2330-2334
34. Wang Y.Q., Luk J.M., Ikeda K., Man K., Chu A.C., Kaneda K., and Fan S.T. Regulatory role of vHL/HIF-1a in hypoxia-induced VEGF production in hepatic stellate cells. Biochem. Biophys. Res. Commun. 317 (2004) 358-362
35. Zhong H., Willard M., and Simons J. NS398 reduces hypoxia-inducible factor (Hif)-1a and Hif-1a activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Int. J. Cancer 112 (2004) 585-595
36. Palayoor S.T., Tofilon P.J., and Coleman C.N. Ibuprofen-mediated reduction of hypoxia- inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin. Cancer Res. 9 (2003) 3150-3157
37. Patel M.I., Subbaramaiah K., Du B., Chang M., Yang P., Newman R.A., et al. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clin. Cancer Res. 11 (2005) 1999-2007
38. Takeda N., Maemura K., Imai Y., Harada T., Kawanami D., Nojiri T., et al. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor flt-1. Circ. Res. 95 (2004) 146-153